Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

Cited by (607)

Items 201–300 of 607

1. Hemostatic and Fibrinolytic Abnormalities in Polycystic Ovary Syndrome
   Giacomo Zoppini, Enzo Bonora, Paolo Moghetti, Giovanni Targher · 2014 · Seminars in Thrombosis and Hemostasis
2. Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects
   Ellen Løkkegaard · 2016 · BMJ Evidence-Based Medicine
3. Venous Thromboembolism Issues in Women
   Birgit Linnemann, Hannelore Rott, Rainer Bernd Zotz, Christina Hart · 2022 · Hämostaseologie
4. Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives
   Jie Li, Genna Panucci, David G. Moeny, Wei Liu, Judith C. Maro, Sengwee Toh, TING-YING JANE HUANG · 2018 · JAMA Internal Medicine
5. CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS
   Vincenzo De Sanctis · 2020 · Mediterranean Journal of Hematology and Infectious Diseases
6. Control of Endothelin-A Receptor Expression by Progesterone Is Enhanced by Synergy With Gata2
   Yanping Zhang, Gregory R. Knutsen, Matthew D. Brown, L. Bruno Ruest · 2013 · Molecular Endocrinology
7. Contemporary Hormonal Contraception and Risk of Venous Thromboembolism
   Harman Gailan Hassan Yonis, Lina Steinrud Mørch, Ellen Løkkegaard, Kristian Hay Kragholm, Amalie Lykkemark Møller, Christian Tobias Torp-Pedersen, Amani Meaidi · 2025 · JAMA
8. Special Considerations for Women of Reproductive Age on Anticoagulation
   Tali Azenkot, Eleanor Bimla Schwarz · 2022 · Journal of General Internal Medicine
9. How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology
   Paolo Moghetti, Enrico Carmina, Vincenzo De Leo, Antonio Lanzone, Francesco Orio, Riccardo Pasquali, Vincenzo Toscano · 2015 · Journal of Endocrinological Investigation
10. Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines
    Steven T. Bird, Abraham G. Hartzema, Mahyar Etminan, James M. Brophy, Joseph A. Delaney · 2013 · Gynecological Endocrinology
11. Contraception hormonale et risque vasculaire. RPC Contraception CNGOF
    Geneviève Plu‐Bureau, Elena Sabbagh, Justine Hugon‐Rodin · 2018 · Gynécologie Obstétrique Fertilité & Sénologie
12. Adverse Effects of Acne Medications: Recognition and Management
    Mollie D. Oudenhoven, Megan A. Kinney, Diana B. McShane, Craig N. Burkhart, Dean S. Morrell · 2015 · American Journal of Clinical Dermatology
13. Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk
    Leslie Skeith, Shannon M. Bates · 2026 · New England Journal of Medicine
14. A review of phase II and III drugs for the treatment and management of endometriosis
    Umberto Perrone, Giulio Evangelisti, Antonio Simone Laganà, Stefano Bogliolo, Marcello Ceccaroni, Alberto Izzotti, Claudio Gustavino, Simone Ferrero, Fabio Barra · 2023 · Expert Opinion on Emerging Drugs
15. Artificial Intelligence in the Management of Women with Endometriosis and Adenomyosis: Can Machines Ever Be Worse Than Humans?
    Giulia Emily Cetera, Alberto Eugenio Tozzi, Valentina Chiappa, Isabella Castiglioni, Camilla Erminia Maria Merli, Paolo Vercellini · 2024 · Journal of Clinical Medicine
16. Thromboembolism as the adverse event of combined oral contraceptives in Japan
    Kazuko Sugiura, Takao Kobayashi, Toshiyuki Ojima · 2015 · Thrombosis Research
17. Blood Pressure and Heart Rate Response to Posteriorly Directed Pressure Applied to the Cervical Spine in Young, Pain-Free Individuals: A Randomized, Repeated-Measures, Double-Blind, Placebo-Controlled Study
    Emmanuel Yung, Michael S. Wong, Haddie Williams, Kyle Mache · 2014 · Journal of Orthopaedic and Sports Physical Therapy
18. A New Contraceptive Pill Containing 17β-Estradiol and Nomegestrol Acetate
    Sophie Christin‐Maître, Emmanuelle Laroche, Léopoldine Bricaire · 2012 · Women s Health
19. Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives
    Svetlana N. Tchaikovski, Stella Thomassen, S. D. Costa, Katarina A Bremme, Jan Rosing · 2014 · Thrombosis Research
20. Risk of Cardiovascular Events with Hormonal Contraception: Insights from the Danish Cohort Study
    Omosalewa O. Lalude · 2013 · Current Cardiology Reports
21. The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism
    Giovanni Grandi, Maria Chiara Del Savio, Fabio Facchinetti · 2021 · Expert Review of Clinical Pharmacology
22. Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications
    Christian Battipaglia, Lia Feliciello, Alessandro David Genazzani, Fabio Facchinetti, Giovanni Grandi · 2023 · Expert Opinion on Drug Metabolism & Toxicology
23. Oestrogens in oral contraception: considerations for tailoring prescription to women’s needs
    Franca Fruzzetti, Tiziana Fidecicchi, Marco Gambacciani · 2024 · The European Journal of Contraception & Reproductive Health Care
24. Long-term cross-sex hormone treatment is safe in transsexual subjects
    Maria Cristina Meriggiola, Marta Berra · 2012 · Asian Journal of Andrology
25. Extended regimens of combined hormonal contraception to reduce symptoms related to withdrawal bleeding and the hormone-free interval: A systematic review of randomised and observational studies
    Nicolás Mendoza, Paloma Lobo, Roberto Lertxundi, Marta Correa, Esteban Gonzalez, Alberto Salamanca, Rafael Sánchez‐Borrego · 2014 · The European Journal of Contraception & Reproductive Health Care
26. Hormonal contraception and pelvic girdle pain during pregnancy: a population study of 91 721 pregnancies in the Norwegian Mother and Child Cohort
    Elisabeth Krefting Bjelland, Per Kristiansson, Hedvig Nordeng, Siri Vangen, Malin Eberhard‐Gran · 2013 · Human Reproduction
27. Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception
    The ESHRE Capri Workshop Group, David T. Baird, Johannes L.H. Evers, Kristina Gemzell‐Danielsson, Anna F. Glasier, S.R. Killick, Paul F. A. Van Look, Paolo Vercellini, Bülent Okan Yıldız, Giuseppe Benagiano et al. · 2012 · Human Reproduction Update
28. Efficacy and safety of the combination of estetrol 15 mg/drospirenone 3 mg in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: a multicenter, placebo-controlled, double-blind, randomized study
    Tasuku Harada, Takao Kobayashi, Akihiro Hirakawa, Toshiaki Takayanagi, Masayoshi Nogami, Takayuki Mochiyama, Masashi Hirayama, Jean‐Michel Foidart, Yutaka Osuga · 2024 · Fertility and Sterility
29. Drospirenone‐containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies
    Natasha Larivée, Samy Suissa, Farzin Khosrow‐Khavar, Vicky Tagalakis, Kristian B. Filion · 2017 · BJOG An International Journal of Obstetrics & Gynaecology
30. The drospirenone (DRSP)-only pill: clinical implications in the daily use
    Ali Kubba, Kristina Gemzell‐Danielsson, Santiago Palacios, Inka Wiegratz, Giovanni Grandi, Enrico Colli, Pedro‐Antonio Regidor · 2023 · The European Journal of Contraception & Reproductive Health Care
31. Clinical practice
    Johan Verhaeghe · 2012 · European Journal of Pediatrics
32. Self-reported family history in estimating the risk of hormone, surgery and cast related VTE in women
    Kristina Sonnevi, Annica Bergendal, Johanna Adami, Gerd Lärfars, Helle Kieler · 2013 · Thrombosis Research
33. Sex hormones and venous thromboembolism – from contraception to hormone replacement therapy
    Jan Beyer‐Westendorf, Rupert Martin Bauersachs, - Viola Hach-Wunderle, Rainer Bernd Zotz, Hannelore Rott · 2018 · VASA
34. Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen
    Hannelore Rott · 2019 · Hämostaseologie
35. Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study
    David Aziz, Leslie Skeith, Marc Alan Rodger, Elham Sabri, Marc Righini, Michael J. Kovacs, Marc Carrier, Susan Rebecca Kahn, Philip Stephen Wells, David R. Anderson et al. · 2021 · Journal of Thrombosis and Haemostasis
36. Contraception in Patients With Heart Failure
    Tara Sedlak, C. Noel Bairey Merz, CHRISANDRA L. SHUFELT, Kimberly D. Gregory, Michèle A. Hamilton · 2012 · Circulation
37. Regulatory T Cell Proportion and Phenotype Are Altered in Women Using Oral Contraception
    Lachlan M. Moldenhauer, Min Jin, Jasmine J. Wilson, Ella S. Green, David J. Sharkey, Mark D. Salkeld, Thomas C Bristow, Mary Louise Hull, Gustaaf Dekker, Sarah Anne Robertson · 2022 · Endocrinology
38. Polycystic ovary syndrome
    Ertuğ Kovanci, John E. Buster · 2015 · Cambridge University Press eBooks
39. Consensus on the investigation of thrombophilia in women and clinical management
    Claudia Mac Donald Bley Nascimento, Andréa Maria Novaes Machado, João Carlos de Campos Guerra, Eduardo Zlotnik, Dirceu Hamilton Cordeiro Campêlo, Paulo Kauffman, Hilton Waksman, Nelson Wolosker, Sérgio Podgaec, Nelson Hamerschlak · 2019 · Einstein (São Paulo)
40. Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged
    William V. Williams, JOEL L. BRIND, Laura Haynes, Michael D. Manhart, Hanna Klaus, Angela Lanfranchi, Gerard Migeon, Mike Gaskins, Elvis I. Šeman, Lester A. Ruppersberger et al. · 2021 · The Linacre Quarterly
41. Overall and bleeding-related discontinuation rates of a new oral contraceptive containing 4 mg drospirenone only in a 24/4 regimen and comparison to 0.075 mg desogestrel
    Pedro‐Antonio Regidor, Enrico Colli, Santiago Palacios · 2021 · Gynecological Endocrinology
42. Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy
    J. F. Petersen, T. Bergholt, A. K. Nielsen, M. J. Paidas, E. C. L. Løkkegaard · 2014 · Thrombosis and Haemostasis
43. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters
    Natasha Larivée, Samy Suissa, Janie Coulombe, Vicky Tagalakis, Kristian B. Filion · 2017 · Drug Safety
44. Contraception
    Courtney A. Schreiber, Kurt Thomas Barnhart · 2019 · Elsevier eBooks
45. Oral combined contraceptives induce liver mitochondrial reactive oxygen species and whole‐body metabolic adaptations in female mice
    Kelly N. Z. Fuller, Colin S. McCoin, Harrison D. Stierwalt, Julie Allen, Shivam Gandhi, Christopher G. R. Perry, Purevsuren Jambal, Kartik Shankar, John P. Thyfault · 2022 · The Journal of Physiology
46. Bleeding Issues in Women Under Oral Anticoagulation
    Lida Kalmanti, Edelgard Lindhoff‐Last · 2022 · Hämostaseologie
47. Oral hormonal contraceptives and cardiovascular risks in females
    Sukhwinder K. Bhullar, Inna Rabinovich-Nikitin, Lorrie A. Kirshenbaum · 2024 · Canadian Journal of Physiology and Pharmacology
48. A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg
    Kristina Biskupska Bodova, Joanna Sójka-Kupny, Tamás Nyirády, Anne E. Burke, Alicyoy Angulo, Pedro‐Antonio Regidor · 2024 · The European Journal of Contraception & Reproductive Health Care
49. Management of Menstrual and Gynecologic Concerns in Girls with Special Needs
    Özlem Dural, İnci Sema Taş, Süleyman Engin Akhan · 2020 · Journal of Clinical Research in Pediatric Endocrinology
50. Modern menstruation: Is it abnormal and unhealthy?
    Norman David Goldstuck · 2020 · Medical Hypotheses
51. Women’s Health and Ulcerative Colitis
    Kindra Clark‐Snustad, Madalina Butnariu, Anita Afzali · 2020 · Gastroenterology Clinics of North America
52. Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives
    Miriam Raps, Joyce Curvers, Frans M. Helmerhorst, Bart E.P.B. Ballieux, Jan Rosing, Stella Thomassen, Frits Richard Rosendaal, Hubertus A.A.M. van Vliet · 2014 · Thrombosis Research
53. Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol
    David F. Archer, Michael A. Thomas, J. Conard, Ruth B. Merkatz, George W. Creasy, Kevin D. Roberts, Marlena Gehret Plagianos, Diana Blithe, Regine L. Sitruk-Ware · 2015 · Contraception
54. Overview of perimenopausal contraception
    Johannes Bitzer · 2018 · Climacteric
55. “One Blood Clot Is One Too Many”: Affected Vocal Users’ Negative Perspectives on Controversial Oral Contraceptives
    Alina Geampana · 2019 · Qualitative Health Research
56. Ethynilestradiol 20 mcg plus Levonorgestrel 100 mcg: Clinical Pharmacology
    Stefano Lello, Andrea Cavani · 2014 · International Journal of Endocrinology
57. Sexual health and contraception in the menopause journey
    Laura Cucinella, Lara Tiranini, Rossella Elena Nappi · 2023 · Best Practice & Research Clinical Endocrinology & Metabolism
58. Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry
    Elvira Grandone, Emilia Antonucci, Donatella Colaizzo, Antonio De Laurenzo, Benilde Cosmi, Michela Cini, Cristina Legnani, Sophie Testa, Maurizio Margaglione, Gualtiero Palareti · 2023 · Thrombosis and Haemostasis
59. Pregnancy, contraception and venous thromboembolism (deep vein thrombosis and pulmonary embolism)
    Allison James · 2017 · Vascular Medicine
60. The incidence and prognosis of thromboembolism associated with oral contraceptives: Age‐dependent difference in Japanese population
    Kazuko Sugiura, Toshiyuki Ojima, Tetsumei Urano, Takao Kobayashi · 2018 · Journal of obstetrics and gynaecology research
61. Polycystic Ovary Syndrome: A Brief Review with Recent Updates
    Shahana Shermin, Aysha Noor, Samsad Jahan · 2020 · Delta Medical College Journal
62. Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis
    Giordana Campos Braga, Milena Bastos Brito, Rui Alberto Ferriani, Luciana Correa Oliveira de Oliveira, Andrea Aparecida Garcia, Maria Carolina Pintão, Carolina Sales Vieira · 2013 · Contraception
63. Contraceptive needs of the adolescent
    Petrus Schonken Steyn, Norman David Goldstuck · 2014 · Best Practice & Research Clinical Obstetrics & Gynaecology
64. Stroke and Etonogestrel/Ethinyl Estradiol Ring (NuvaRing): Clinical, Radiological, and Prognostic Features
    Prad Selvan, Pirouz Piran, Clotilde Balucani, Brian Tark, Zachary Adler, Steven R. Levine · 2016 · Journal of Stroke and Cerebrovascular Diseases
65. Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database
    Shiori Hasegawa, Toshinobu Matsui, Yuuki Hane, Junko Abe, Haruna Hatahira, Yumi Motooka, Sayaka Sasaoka, Akiho Fukuda, Misa Naganuma, Kouseki Hirade et al. · 2017 · PLoS ONE
66. The epidemiological characteristics of thromboembolism related to oral contraceptives in Japan: Results of a national survey
    Kazuko Sugiura, Takao Kobayashi, Toshiyuki Ojima · 2020 · Journal of obstetrics and gynaecology research
67. Thrombophilia
    Andrew N Nicolaides, Jawed Fareed, A. K. Kakkar, A. J. Comerota, Samuel Zachary Goldhaber, R. Hull, K. Myers, Meyer Michel Samama, Jane M. Fletcher, Evi Kalodiki et al. · 2013 · Clinical and Applied Thrombosis/Hemostasis
68. The Prescribing of Contraceptives for Adolescents in German Gynecologic Practices in 2007 and 2011: A Retrospective Database Analysis
    M. Ziller, Asia N Rashed, Volker Ziller, Karel Kostev · 2013 · Journal of Pediatric and Adolescent Gynecology
69. Oral hormonal contraception and venous thromboembolism (VTE)
    Robert L. Reid · 2014 · Contraception
70. Contraceptives and Thrombosis: An Intertwined Revolutionary Road
    Doris Barcellona, Francesco Marongiu, Elvira Grandone · 2023 · Seminars in Thrombosis and Hemostasis
71. Contraception in obese older women
    Rosemary A. Cochrane, Ailsa E. Gebbie, Joanna C. Loudon · 2012 · Maturitas
72. Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
    Thomas Römer, Johannes Bitzer, Christian Egarter, Peyman Hadji, Marion B. Kiechle, Heike Krämer, Patricia G. Oppelt, Klaus Peters, Petra Stute, Katrin Schaudig et al. · 2021 · Geburtshilfe und Frauenheilkunde
73. A Review of Hormonal Contraception and Venous Thromboembolism in Adolescents
    Gary M. Woods, Bryce A. Kerlin, Sarah H. O’Brien, Andrea Elena Bonny · 2015 · Journal of Pediatric and Adolescent Gynecology
74. Combined Oral Contraceptives and Vascular Thrombosis: A Single-Center Experience
    Mohammed Abdullah Alsheef, Yacoub Abuzied, Ghady R Alzahrani, Nihal AlAraj, Nada AlAqeel, Hala Aljishi, Mukhtar Alomar, Abdul Rehman Zia Zaidi, Ohoud Alarfaj · 2022 · Cureus
75. The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review
    Giovanni Grandi, Gloria Guariglia, Fabio Facchinetti · 2023 · The European Journal of Contraception & Reproductive Health Care
76. Pharmacologic Management of Types 1 and 2 Diabetes Mellitus and Their Complications in Women of Childbearing Age
    Mimi S. Mukherjee, Valerie Azzopardi Coppenrath, Bree A. Dallinga · 2015 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
77. Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women
    Takao Kobayashi, Kazuko Sugiura, Toshiyuki Ojima · 2017 · Journal of obstetrics and gynaecology research
78. Women’s health in The BMJ : a data science history
    Eva N. Hamulyák, Austin J. Brockmeier, Johanna D Killas, Sophia Ananiadou, Saskia Middeldorp, Armand Marie Leroi · 2020 · BMJ Open
79. Contraception and Cardiovascular Effects: What Should the Cardiologist Know?
    Anhthu Trinh, Ankit Vyas, Anna K Roselle, Dhivya Velu, Lekha S. Hota, Madhavi Kadiyala · 2023 · Current Cardiology Reports
80. Reversible female contraceptives: historical, current, and future perspectives
    Brooke E Barton, Jeffery A. Erickson, Stephanie Allred, Jenna M Jeffries, Kalli K. Stephens, Mark I Hunter, Kirby A Woodall, Wipawee Winuthayanon · 2023 · Biology of Reproduction
81. Contraceptive counselling and uptake of contraception among women with cardiovascular diseases: a systematic review and meta-analysis
    Tesfaye Regassa Feyissa, Shahinoor Akter, Melissa L. Harris · 2024 · Clinical Research in Cardiology
82. Effect over coagulation and fibrinolysis parameters of a prolonged release 24 + 4 daily use regime contraceptive formulation containing 2 mg dienogest/0.02 mg ethinylestradiol
    Pedro‐Antonio Regidor, Alicyoy Angulo, Enrico Colli · 2025 · Gynecological Endocrinology
83. Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in men
    Daniel Ezzat, Diana M. Lopez, Brian Lee Claggett, Linke Li, Niekbachsh Mohammadnia, Art Schuermans, Jan Hemeryck, Annie Chang, Samantha Murillo, Michelle L. O’Donoghue et al. · 2026 · European Heart Journal
84. Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants
    Rajinder Bhardwaj, Joseph Stringfellow, Beth A. Morris, Robert S. Croop, Richard Bertz · 2023 · Headache The Journal of Head and Face Pain
85. Hospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia
    Marloe Prince, Charles J. Glueck, Parth K. Shah, Ashwin Kumar, Michael Goldenberg, Matan Rothschild, Nasim Motayar, Vybhav Jetty, Kevin Lee, Ping Wang · 2016 · BMC Hematology
86. An opinion on the benefits of concomitant oral contraceptive therapy in premenopausal women treated with oral anticoagulants
    Richard Godin, Geneviève Roy, James Demetrios Douketis · 2018 · Thrombosis Research
87. Contraceptive Counseling for the Transgender Patient Assigned Female at Birth
    Sérgio Henrique Pires Okano, Giovanna Giulia Milan Pellicciotta, Giordana Campos Braga · 2022 · Revista Brasileira Ginecologia e Obstetrícia
88. Bridging gap in treatment of polycystic ovarian syndrome through drug repurposing: what we achieved and where we are?
    Popat Kumbhar, Revati Chavan, Snehal Darekar, Kaustubh Ajit Kolekar, Anvitha Sequeira, Sukriti Vishwas, Guarav Gupta, Keshav Raj Paudel, Sachin Kumar Singh, Kamal Dua et al. · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
89. Ischemic Stroke in Users of Combined Hormonal Contraceptives: A Danish Registry Study
    Gasper Letnar, Klaus Kaae Andersen, Tom Skyhøj Olsen · 2024 · Stroke
90. Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women
    Rossella Elena Nappi, Anna Maria Paoletti, Annibale Volpe, Luca Chiovato, Brandon K. Howard, Herman Weiss, Nancy A. Ricciotti · 2014 · The European Journal of Contraception & Reproductive Health Care
91. Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case–control studies using the QResearch and the CPRD databases
    Yana Vinogradova, Carol A. C. Coupland, Julia Hippisley‐Cox · 2014 · BMJ Open
92. Cyproterone acetate–ethinyl estradiol use in a 23-year-old woman with stroke
    Julie Anne Kromm, Thomas Jeerakathil · 2014 · Canadian Medical Association Journal
93. Adolescent girls in Denmark use oral contraceptives at an increasingly young age, and with more pauses and shifts.
    Ellen Løkkegaard, Anne Kristine Nielsen · 2014 · PubMed
94. The Impact of Hormonal Contraceptives on the Incidence and Progression of Cardiovascular Diseases in Women: A Systematic Review
    Joshua Asubiaro · 2024 · Cureus
95. Chapter 3. Impact of estrogens on hemostasis
    Frank Z. Stanczyk, Intira Sriprasert, Shinnisha Chulapongwanich, Jane L. Yang, Franca Fruzzetti · 2025 · Frontiers in Endocrinology
96. Synthetic Hormones and Clot Formation
    Albe C. Swanepoel, Amcois Visagie, Etheresia Pretorius · 2016 · Microscopy and Microanalysis
97. Update on specificities of stroke in women
    Hanne Christensen, Line Bentsen, Louisa Marguerite Christensen · 2016 · La Presse Médicale
98. The synthetic progestin, gestodene, affects functional biomarkers in neonatal rat osteoblasts through an estrogen receptor-related mechanism of action
    Juana Enríquez, Gustavo García, Bertha Herrero, Fernando Larrea · 2017 · Endocrine Research
99. Oral contraception in women with mild thrombophilia: What have we learned recently?
    Ángeles Blanco-Molina · 2012 · Thrombosis Research
100. Managing Heavy Menstrual Bleeding in Women at Risk of Thrombosis
     Andrew Rivara, Allison James · 2018 · Clinical Obstetrics & Gynecology